These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27589034)

  • 1. Solid-State NMR Studies Reveal Native-like β-Sheet Structures in Transthyretin Amyloid.
    Lim KH; Dasari AK; Hung I; Gan Z; Kelly JW; Wright PE; Wemmer DE
    Biochemistry; 2016 Sep; 55(37):5272-8. PubMed ID: 27589034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.
    Lim KH; Dasari AK; Hung I; Gan Z; Kelly JW; Wemmer DE
    Biochemistry; 2016 Apr; 55(13):1941-4. PubMed ID: 26998642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.
    Lim KH; Dasari AKR; Ma R; Hung I; Gan Z; Kelly JW; Fitzgerald MC
    Biochemistry; 2017 Sep; 56(36):4808-4818. PubMed ID: 28820582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomy of an amyloidogenic intermediate: conversion of beta-sheet to alpha-sheet structure in transthyretin at acidic pH.
    Armen RS; Alonso DO; Daggett V
    Structure; 2004 Oct; 12(10):1847-63. PubMed ID: 15458633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.
    Dasari AKR; Hung I; Gan Z; Lim KH
    Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):344-349. PubMed ID: 30366153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril.
    Jaroniec CP; MacPhee CE; Astrof NS; Dobson CM; Griffin RG
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16748-53. PubMed ID: 12481032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.
    Dasari AKR; Hughes RM; Wi S; Hung I; Gan Z; Kelly JW; Lim KH
    Sci Rep; 2019 Jan; 9(1):33. PubMed ID: 30631096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy.
    Jaroniec CP; MacPhee CE; Bajaj VS; McMahon MT; Dobson CM; Griffin RG
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):711-6. PubMed ID: 14715898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin.
    Bateman DA; Tycko R; Wickner RB
    Biophys J; 2011 Nov; 101(10):2485-92. PubMed ID: 22098747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.
    Zhou S; Cheng J; Yang T; Ma M; Zhang W; Yuan S; Lo GV; Dou Y
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31861226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo.
    Dasari AKR; Hung I; Michael B; Gan Z; Kelly JW; Connors LH; Griffin RG; Lim KH
    Biochemistry; 2020 May; 59(19):1800-1803. PubMed ID: 32338497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations.
    Leach BI; Zhang X; Kelly JW; Dyson HJ; Wright PE
    Biochemistry; 2018 Jul; 57(30):4421-4430. PubMed ID: 29972637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.
    Cordeiro Y; Kraineva J; Suarez MC; Tempesta AG; Kelly JW; Silva JL; Winter R; Foguel D
    Biophys J; 2006 Aug; 91(3):957-67. PubMed ID: 16698785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of peptide fragment 71-93 of transthyretin by NMR spectroscopy and electron microscopy: insight into amyloid fibril formation.
    Jarvis JA; Munro SL; Craik DJ
    Biochemistry; 1994 Jan; 33(1):33-41. PubMed ID: 8286355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.
    Colon W; Kelly JW
    Biochemistry; 1992 Sep; 31(36):8654-60. PubMed ID: 1390650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting the inter-peptide arrangement and maturation process of transthyretin (105-115) amyloid fibril using a FRET pair with short Förster distance.
    Deng W; Cao A; Lai L
    Biochem Biophys Res Commun; 2007 Oct; 362(3):689-94. PubMed ID: 17761149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD and Solid-State NMR Studies of Low-Order Oligomers of Transthyretin.
    Dasari AKR; Lim KH
    Methods Mol Biol; 2023; 2551():311-320. PubMed ID: 36310212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy.
    Olofsson A; Ippel JH; Wijmenga SS; Lundgren E; Ohman A
    J Biol Chem; 2004 Feb; 279(7):5699-707. PubMed ID: 14604984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states.
    Das JK; Mall SS; Bej A; Mukherjee S
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12781-4. PubMed ID: 25251500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.